Magnetic resonance spectroscopy for evaluation of suspected brain tumor. [electronic resource]
- TEC bulletin Mar 2003
- 23-6 p. digital
Publication Type: Journal Article
1543-1622
Blue Cross Blue Shield Insurance Plans Brain Neoplasms--diagnosis Device Approval Drug Approval Evidence-Based Medicine Humans Insurance Coverage Magnetic Resonance Spectroscopy Outcome Assessment, Health Care Protons Technology Assessment, Biomedical United States United States Food and Drug Administration